share_log

P3 Health Partners to Become Publicly Traded via Merger with Foresight Acquisition Corp.; Estimated Post-Transaction Enterprise Value of $2.3B

P3 Health Partners to Become Publicly Traded via Merger with Foresight Acquisition Corp.; Estimated Post-Transaction Enterprise Value of $2.3B

P3 Health Partners將通過與Foresight Acquisition Corp.合併上市;交易後企業價值估計為23億美元
Benzinga Real-time News ·  2021/05/26 03:25

- Transaction to Publicly List P3 Health Partners, a Patient-Centered and Physician-Led Population Health Management Company Delivering Value-Based Care -

-將P3 Health Partners公開上市的交易,P3 Health Partners是一家以患者為中心、以醫生為主導的人口健康管理公司,提供基於價值的護理-

- Estimated Post-Transaction Enterprise Value of $2.3 Billion With Over $180 Million in Cash to Fund Growth -

-交易後企業價值估計為23億美元,現金到基金增長超過1.8億美元-

- Transaction Includes an Over $200 Million Fully Committed Common Stock Private Investment at $10 Per Share Including Participation From Funds and Accounts Managed by Fidelity Management & Research Company LLC and Janus Henderson Investors -

-交易包括一項超過2億美元的全額承諾普通股私人投資,每股10美元,包括富達管理和研究公司(Fidelity Management&Research Company LLC)和Janus Henderson Investors管理的基金和賬户的參與-

P3 Health Partners (“P3”) and Foresight Acquisition Corp. (NASDAQ:FORE) (“Foresight”) have entered into a definitive agreement which would result in P3 becoming a publicly listed company.

P3健康夥伴公司(以下簡稱“P3”)和展望公司(納斯達克代碼:FOREST)(以下簡稱“展望公司”)已經達成一項最終協議,這將使P3公司成為一家公開上市公司。

Upon closing of the transaction, the combined entity will be renamed P3 Health Partners and is expected to remain listed on the Nasdaq Capital Market.

交易完成後,合併後的實體將更名為P3健康合作伙伴,預計將繼續在納斯達克資本市場上市。

P3 is a patient-centered and physician-led population health management company that supports providers, physicians, and practices in their journey from traditional volume-based models to value-based systems of care and wellness. P3 believes its extensive experience managing Medicare Advantage (MA) populations in global risk arrangements drives its differentiated model, which simultaneously improves care and decreases costs. P3 is a portfolio company of Chicago Pacific Founders who provided P3’s initial and growth capital.

P3是一家以患者為中心、以醫生為主導的人口健康管理公司,在從傳統的體量模式到基於價值的護理和健康系統的過程中,為提供者、醫生和診所提供支持。P3認為,其在全球風險安排中管理聯邦醫療保險優勢(MA)人羣的豐富經驗推動了其差異化模式,該模式同時改善了醫療保健,降低了成本。P3是芝加哥太平洋基金公司(Chicago Pacific Founders)的投資組合公司,為P3提供了初始和增長資本。

P3 Health Partners Investment Highlights

P3健康合作伙伴投資亮點

  • Empowering Value-Based Care: Founded and led by physicians, P3 is a team of doctors, clinicians and support service professionals with a shared passion for delivering value-based care. P3 is dedicated to transforming healthcare for patients, providers, and payors with a proven physician-affiliated model that delivers high-quality, low-cost care to Medicare Advantage members.

  • Large Addressable Market for Medicare Advantage Patients: Substantial market opportunity to partner with physicians & payors that serve the 60 million estimated Medicare eligible beneficiaries in P3’s rapidly growing core $300 billion Medicare Advantage Market. P3 currently operates in 11 markets across four states and expects to add three to five new markets annually to drive 35% patient growth over the long-term through a mix of payor and provider opportunities.

  • Rapidly Scalable, Capital-Light Model: P3’s capital efficient growth approach leverages the existing installed physician base across the U.S., which enables accelerated market entry while maintaining the preexisting patient and physician relationship. P3 enters markets with payor and provider partnerships to rapidly scale member growth while developing a full network of primary care, specialty, and ancillary providers.

  • Experienced Management Team: P3 was founded and is led by one of the most experienced management teams in population health. The core management team has a 20-year track record with deep value-based care expertise and a proven ability to build and scale value-based care platforms.

  • 增強基於價值的關懷:P3由醫生創建和領導,是一個由醫生、臨牀醫生和支持服務專業人員組成的團隊,他們對提供基於價值的護理有着共同的熱情。P3致力於轉變患者、提供者和付款人的醫療保健,採用經過驗證的醫生附屬模式,為Medicare Advantage成員提供高質量、低成本的醫療服務。

  • 面向Medicare Advantage患者的巨大潛在市場:在P3快速增長的3000億美元的核心醫療保險優勢市場中,與醫生和付款人合作的巨大市場機會,這些醫生和付款人服務於約6000萬符合聯邦醫療保險資格的受益者。P3目前在四個州的11個市場運營,預計每年將增加3到5個新市場,通過支付者和提供者機會的組合,長期推動患者增長35%。

  • 可快速擴展的輕量級資本模式:P3的資本效率增長方法利用了美國各地現有的已安裝醫生基礎,從而在保持原有的患者和醫生關係的同時,加快了進入市場的速度。P3通過付款人和提供者的合作伙伴關係進入市場,以快速擴大會員增長,同時發展初級保健、專科和輔助提供者的完整網絡。

  • 經驗豐富的管理團隊:P3是由人口健康領域最有經驗的管理團隊之一創立並領導的。核心管理團隊擁有20年的跟蹤記錄,擁有深厚的基於價值的護理專業知識,並具有構建和擴展基於價值的護理平臺的成熟能力。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論